Document is current
Any future updates will be listed below
-
Authors
Ellis, Elizabeth G. https://orcid.org/0000-0001-7977-6693
Meyer, Garance M.
Kaasinen, Valtteri https://orcid.org/0000-0002-3446-7093
Corp, Daniel T.
Pavese, Nicola
Reich, Martin M. https://orcid.org/0000-0001-9115-5136
Joutsa, Juho https://orcid.org/0000-0002-3457-9415
- License Information
-
More Information
Article History
Received: 2 February 2024
Accepted: 5 August 2024
First Online: 14 August 2024
Competing interests
: E.G.E, G.M.M., and D.T.C., declare no competing financial or non-financial Interests. V.K. serves as an advisory board member of AbbVie Finland and Nordic Infucare AB, has received travel expenses and speaker honoraria from Abbvie Finland, Nordic Infucare AB and Orion Pharma and research funding from the Finnish Alcohol Research Foundation, the Päivikki and Sakari Sohlberg Foundation, the Finnish Cultural Foundation, the International Parkinson and Movement Disorder Society, and Finnish governmental research funding (VTR). N.P. declares no competing financial interests related to the present article; his contribution to this article reflects entirely and only his own academic expertise on the matter. He has received <i>Advisory Boards honoraria from: Britannia, Bial, Boston Scientific, Benevolent AI, Roche, Abbvie. 4D Pharma; Speaker Honoraria from: Britannia, Abbvie, GE Healthcare, Boston Scientific, the MDS. He has received research grants from the Independent Research Fund Denmark, Danish Parkinson’s disease Association, Parkinson’s UK, Center of Excellence in Neurodegeneration (CoEN) network award, GE Healthcare Grant, Multiple System Atrophy Trust, Weston Brain Institute, EU Joint Program Neurodegenerative Disease Research (JPND), the MJFF, and the EU Horizon 2020 research and innovation programme</i>. M.M.R. reports grant support and honoraria for speaking from Medtronic and Boston Scientific, outside the submitted and was supported by the German Research Foundation (DFG, Project-ID424778381, TRR 295) and the German Federal Ministry of Education and Research (BMBF, 01KG2032_DIPS). J.J. has received research funding from the Finnish Medical Foundation, Sigrid Juselius Foundation, and Finnish Foundation for Alcohol Studies, lecturer honoraria from Lundbeck and Novartis, conference travel support from Abbvie, Abbott and Insightec, and consultancy fees from Summaryx and Adamant Health.
